Mettler-Toledo International Inc. (NYSE:MTD) Receives $1,338.75 Average PT from Brokerages

Mettler-Toledo International Inc. (NYSE:MTD) has received a consensus rating of “Reduce” from the eight research firms that are presently covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and one has assigned a buy rating to the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $1,338.75.

MTD has been the topic of several recent analyst reports. Wells Fargo & Company cut their target price on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a research note on Monday, November 11th. Robert W. Baird reduced their price objective on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a research note on Monday, November 11th. Stifel Nicolaus lowered their target price on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating on the stock in a research note on Monday, November 11th. Evercore ISI increased their price target on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 1st. Finally, JPMorgan Chase & Co. raised their price target on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the stock a “neutral” rating in a report on Monday, August 5th.

Mettler-Toledo International Stock Up 0.9 %

NYSE:MTD opened at $1,243.40 on Tuesday. The stock has a fifty day simple moving average of $1,348.27 and a 200 day simple moving average of $1,395.43. The firm has a market capitalization of $26.24 billion, a price-to-earnings ratio of 33.52, a price-to-earnings-growth ratio of 4.04 and a beta of 1.16. Mettler-Toledo International has a 1-year low of $1,059.08 and a 1-year high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 EPS for the quarter, topping the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a net margin of 21.15% and a negative return on equity of 531.78%. The company had revenue of $954.54 million during the quarter, compared to analysts’ expectations of $941.93 million. Equities analysts predict that Mettler-Toledo International will post 40.39 earnings per share for the current year.

Insider Activity at Mettler-Toledo International

In related news, Director Elisha W. Finney sold 76 shares of the company’s stock in a transaction on Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total value of $99,693.00. Following the completion of the sale, the director now directly owns 240 shares in the company, valued at approximately $314,820. This represents a 24.05 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 1.94% of the company’s stock.

Institutional Trading of Mettler-Toledo International

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. EverSource Wealth Advisors LLC raised its stake in shares of Mettler-Toledo International by 8.0% in the 1st quarter. EverSource Wealth Advisors LLC now owns 95 shares of the medical instruments supplier’s stock valued at $117,000 after acquiring an additional 7 shares in the last quarter. UMB Bank n.a. lifted its stake in shares of Mettler-Toledo International by 6.6% in the second quarter. UMB Bank n.a. now owns 113 shares of the medical instruments supplier’s stock worth $158,000 after buying an additional 7 shares during the last quarter. Massmutual Trust Co. FSB ADV boosted its holdings in shares of Mettler-Toledo International by 7.2% during the 2nd quarter. Massmutual Trust Co. FSB ADV now owns 119 shares of the medical instruments supplier’s stock worth $166,000 after buying an additional 8 shares during the period. DT Investment Partners LLC grew its stake in Mettler-Toledo International by 13.3% in the 3rd quarter. DT Investment Partners LLC now owns 68 shares of the medical instruments supplier’s stock valued at $102,000 after buying an additional 8 shares during the last quarter. Finally, Suncoast Equity Management raised its holdings in Mettler-Toledo International by 2.0% in the 3rd quarter. Suncoast Equity Management now owns 460 shares of the medical instruments supplier’s stock worth $690,000 after acquiring an additional 9 shares during the period. Institutional investors and hedge funds own 95.07% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.